Goldman Sachs Group Inc Ampio Pharmaceuticals, Inc. Transaction History

Goldman Sachs Group Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 May 14, 2024	SELL	$0.08 - $21.0 $1,404 - $368,739	-17,559 Reduced 26.86%	47,814 $3,000
Q3 2022 Nov 10, 2022	SELL	$0.08 - $21.0 $1,404 - $368,739	-17,559 Reduced 26.86%	47,814 $0
Q2 2022 May 14, 2024	BUY	$0.16 - $0.47 $10,459 - $30,725	65,373 New	65,373 $11,000
Q2 2022 Aug 15, 2022	BUY	$0.16 - $0.47 $951 - $2,795	5,948 Added 10.01%	65,373 $11,000
Q1 2022 May 16, 2022	SELL	$0.42 - $0.62 $61,137 - $90,250	-145,565 Reduced 71.01%	59,425 $28,000
Q4 2021 Feb 14, 2022	BUY	$0.56 - $1.71 $40,426 - $123,446	72,191 Added 54.36%	204,990 $118,000
Q3 2021 Nov 10, 2021	BUY	$1.21 - $1.8 $160,686 - $239,038	132,799 New	132,799 $220,000

96.6K

Ticker AMPE
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 226,287,008
Description
Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.